Park Jenn J, Boyd Carter J, Hemal Kshipra, Sorenson Thomas J, Amro Chris, Vernice Nicholas A, Lakatta Alexis C, Cohen Oriana, Choi Mihye, Karp Nolan S
Hansjorg Wyss Department of Plastic Surgery, New York University Langone Health, 550 1st Ave, New York, NY 10016, USA.
J Clin Med. 2025 Jun 19;14(12):4363. doi: 10.3390/jcm14124363.
Nipple-sparing mastectomy (NSM), given demonstrated oncologic safety, is widely used for both therapeutic and prophylactic mastectomy. The popularity of NSM has spurred advancements by breast and plastic surgeons, liberalizing the indications for NSM and improving patient and aesthetic reconstructive outcomes. This review explores these developments and establishes up-to-date surgical tenets for successful NSM and reconstruction. A comprehensive literature review was conducted using the PubMed, Google Scholar, and Cochrane Library databases, focusing on peer-reviewed studies published up to 2024. Articles were selected based on relevance, quantity, and documentation of clinical outcomes and patient satisfaction. NSM is utilized frequently for both invasive breast cancers and prophylactic mastectomy, with expanded criteria for candidacy by breast surgeons. Staged procedures such as adjunct reduction, mastopexy, or nipple delay allow patients with larger or ptotic breasts to undergo NSM with comparable outcomes. Long-term outcome studies have identified important risk factors for complications, including smoking history, higher mastectomy weight, certain medical comorbidities, and suboptimal mastectomy flaps. Evolutions in reconstructive decision making in direct-to-implant and staged tissue expander placement have improved aesthetic results while accounting for poor mastectomy flap quality or adjuvant therapy. Long-term outcomes show NSM remains safe and has comparable rates of local recurrence. Patient-reported outcomes demonstrate satisfaction with NSM, especially in sexual and psychological wellbeing metrics. NSM has been demonstrated to be safe in long-term oncologic outcomes. Its widespread popularity over the past ten years has helped identify methods to improve upon surgical and aesthetic outcomes, including decision-making in reconstruction; considerations for challenging patient-related characteristics such as macromastia, ptosis, and NAC asymmetry; and novel advances in areas such as neurotization.
保留乳头的乳房切除术(NSM),鉴于已证实的肿瘤学安全性,广泛应用于治疗性和预防性乳房切除术。NSM的普及促使乳腺外科医生和整形外科医生取得了进展,放宽了NSM的适应症,并改善了患者的美学重建效果。本文综述探讨了这些进展,并确立了成功进行NSM和重建的最新手术原则。使用PubMed、谷歌学术和考克兰图书馆数据库进行了全面的文献综述,重点关注截至2024年发表的同行评审研究。根据相关性、数量以及临床结果和患者满意度的记录来选择文章。NSM常用于浸润性乳腺癌和预防性乳房切除术,乳腺外科医生扩大了候选标准。诸如辅助性乳房缩小术、乳房上提术或乳头延迟术等分期手术,使乳房较大或下垂的患者能够接受NSM并获得可比的结果。长期结果研究确定了并发症的重要风险因素,包括吸烟史、乳房切除重量较大、某些内科合并症以及乳房切除皮瓣不理想。直接植入假体和分期组织扩张器植入的重建决策的演变,在考虑乳房切除皮瓣质量差或辅助治疗的同时改善了美学效果。长期结果表明,NSM仍然安全,局部复发率相当。患者报告的结果显示对NSM满意,尤其是在性健康和心理健康指标方面。NSM已被证明在长期肿瘤学结果方面是安全的。在过去十年中,它的广泛普及有助于确定改善手术和美学效果的方法,包括重建决策;对具有挑战性的患者相关特征(如巨乳症、乳房下垂和乳头乳晕复合体不对称)的考虑;以及神经化等领域的新进展。